Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 3
1(33.3%)
N/A
1(33.3%)
Phase 2
1(33.3%)
3Total
Phase 3(1)
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04875884Not ApplicableRecruiting

Optimized MRI of Patients With Hip Arthroplasty

Role: collaborator

NCT05979415Phase 2Terminated

Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes

Role: collaborator

NCT00591591Phase 3Completed

Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers

Role: lead

All 3 trials loaded